Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF) by Sungji Cho, Keith Dadson, Hye Kyoung Sung, Oyeronke Ayansola, Ali Mirzaesmaeili, Nina Noskovicova, Yimu Zhao, Krisco Cheung, Milica Radisic, Boris Hinz, Ali A. Abdul Sater, Henry H. Hsu, Gary D. Lopaschuk, Gary Sweeney

Get full text